Solara Active Pharma Sciences Limited Share Price

Equities

SOLARA

INE624Z01016

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:54 24/05/2024 pm IST 5-day change 1st Jan Change
463.6 INR -1.41% Intraday chart for Solara Active Pharma Sciences Limited -4.74% +28.37%
Sales 2024 * 14.31B 172M Sales 2025 * 17.07B 206M Capitalization 22.25B 268M
Net income 2024 * -3.21B -38.67M Net income 2025 * 293M 3.53M EV / Sales 2024 * 1.56 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
-
P/E ratio 2025 *
56.9 x
Employees 2,361
Yield 2024 *
-
Yield 2025 *
0.65%
Free-Float 40.96%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Solara Active Pharma Sciences Limited

1 day-1.41%
1 week-4.74%
Current month-12.96%
1 month-15.95%
3 months-5.10%
6 months+38.28%
Current year+28.37%
More quotes
1 week
460.35
Extreme 460.35
503.00
1 month
460.35
Extreme 460.35
564.00
Current year
350.00
Extreme 350
606.40
1 year
286.00
Extreme 286
606.40
3 years
286.00
Extreme 286
1 839.00
5 years
273.00
Extreme 273
1 859.95
10 years
134.50
Extreme 134.5
1 859.95
More quotes
Managers TitleAgeSince
Chief Executive Officer - 03/23/03
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 52 01/19/01
Members of the board TitleAgeSince
Director/Board Member 63 -
Chief Operating Officer 52 01/19/01
Director/Board Member 40 16/19/16
More insiders
Date Price Change Volume
24/24/24 463.6 -1.41% 89,601
23/24/23 470.2 -3.11% 131,909
22/24/22 485.4 -0.41% 127,258
21/24/21 487.4 +0.67% 243,644
18/24/18 484.1 -0.52% 18,838

Delayed Quote NSE India S.E., May 24, 2024 at 05:13 pm IST

More quotes
Solara Active Pharma Sciences Limited is an India-based company offering diversified, commercial active pharmaceutical ingredients (APIs) and contract manufacturing services in over 70 countries. The Company operates through the API segment. Its commercial and research and development products include Albendazole, Aprepitant (Antiemetic), Artesunate, Brivaracetam (Antiepileptic), Bumetanide (Inj) (Loop Diuretic), Buspirone HCL (Anxiolytic), Cetirizine Dihydrochloride, Chlorpromazine Hydrochloride, Cinacalcet Hydrochloride (Calcimimetic Agent), Citicoline Sodium (Anticonvulsant), Colchicine (Antigout Agent), Colesevelam Hydrochloride, Cycloserine (Antitubercular), Ethacrynic Acid (Cardiovascular Agent), Hydralazine Hydrochloride (Anti-Hypertensive), Ibuprofen Sodium Dihydrate (Anti-inflammatory), Mesna (Antineoplastic Detoxifying Agent), Mirabegron (OAB Treatment), Pentoxifylline, and others. The Company works with pharmaceutical companies from North America, Europe, and Japan.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
463.6 INR
Average target price
350 INR
Spread / Average Target
-24.50%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. SOLARA Stock